Primary degenerative mild cognitive impairment: Study population, clinical, brain imaging and biochemical findings

Dementia and Geriatric Cognitive Disorders

Volumn 12, Issue 6, 2001, Pages 379-386

  Lautenschlager, Nicola T ^a,b   Riemenschneider, Matthias ^a   Drzezga, Alexander ^a   Kurz, Alexander F ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Alzheimer's disease; Diagnostic markers; Mild cognitive impairment

Indexed keywords

BIOCHEMICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOCHEMISTRY; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; IMAGING; MALE; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; PRIORITY JOURNAL;

AGED; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; BRAIN; COGNITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SYNDROME; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035742792     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051284     Document Type: Article

References (41)

1. Klinik der psychopathologie der organischen psychosen
2. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health Work Group
3. Criteria for diagnosing age-associated memory impairment: Proposed improvements from the field
4. Working Party of the International Psychogeriatric Association: Aging-associated cognitive decline
5. What's in a name - Dementia or dysmentia?
6. Cognitive impairment in the nondemented elderly
7. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study
8. Normal aging, mild cognitive impairment, and early Alzheimer's disease
9. The Clinical Dementia Rating (CDR): Current version and scoring rules
10. Clinical dementia rating training and reliability in multicenter studies: The Alzheimer's Disease Cooperative Study experience
11. Rate of dementia of the Alzheimer type (DAT) in subjects with mild cognitive impairment
12. Very mild senile dementia of the Alzheimer type: Clinical assessment
13. Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia
14. Mild cognitive impairment: Clinical characterization and outcome
15. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease
16. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). IV. Rating of cognitive change in the longitudinal assessment of probable Alzheimer's disease
17. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures
18. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). V. A normative study of the neuropsychological battery
19. CERAD - Neuropsychological battery - A minimal data set to be used as a common assessment tool of dementia
20. The CERAD neuropsychological assessment battery (CERAD-NAB): A minimal data set as a common tool for German-speaking Europe
21. The challenge of time: Clock-drawing and cognitive function in the elderly
22. Development and validation of a geriatric depression screening scale: A preliminary report
23. Was leistet die Deutsche version der geriatrischen depressionsskala (GDS)?
24. Short version of the geriatric depression scale: A study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV
25. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay
26. Improved discriminaton of AD patients using β-amyloid (1-42) and tau levels in CSF
27. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluoride-18-FDG PET
28. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
29. Eine systematische genetisch-epidemiologische familenerhebung bei Alzheimererkranken - Erfahrungen mit der MIRAGE-Studie in Deutschland
30. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
31. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
32. Apolipoprotein E type 4 allele and Alzheimer's disease: Effect on age at onset and relative risk in different age groups
33. Phenotypical subgroups of Alzheimer's disease: Relevance for clinical course and survival
34. Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type
35. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type
36. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals
37. Hippocampal volume losses in minimally impaired elderly
38. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease
39. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
40. Identification of cognitive impairment in the elderly: Homocysteine is an early marker
41. Homocysteine and neurological disease